Excerpts from
Public Law
107-116 Signed by President Bush 1/10/02
Departments
of Labor, Health, and Human Services, and Education, and
Related
Agencies Appropriations Act 2002
Senate
Appropriations Report Language - S.1536,
SR.107-84.
Centers for
Disease Control and Prevention
Lyme Disease -
The Committee is deeply concerned
about the safety of
the Lyme disease vaccine (LymeRix). Over 1,000 adverse event reports
were
filed with the Food and Drug Administration from December 1998 to
October
2000. The Committee encourages CDC to work closely with the FDA to
ensure
that all adverse event reports are thoroughly and expeditiously
investigated
to ensure public safety as the vaccine is being distributed.
Investigators
should pay particular attention to patients' reports of arthritis when
evaluating these reports.
The Committee
recognizes that the
current state of laboratory
testing for Lyme disease is very poor. The
situation has led many
people to be misdiagnosed and delayed
proper
treatment. The vaccine clinical trial has documented that more that one
third (36 percent) of the people with Lyme disease did not test
positive
on the most sophisticated tests available. The ramifications of this
deficit
in terms of unnecessary pain, suffering and cost is staggering. The
Committee
directs CDC to work closely with the Food and Drug Administration to
develop
an unequivocal test for Lyme disease.
The
Committee is distressed in hearing of the
widespread misuse of the
current Lyme disease surveillance case definition. While the CDC does
state
that 'this surveillance case definition was developed for national
reporting
of Lyme disease: it is NOT appropriate for clinical diagnosis,' the
definition
is reportedly misused as a standard of care for healthcare
reimbursement,
product (test) development, medical licensing hearings, and other legal
cases. The CDC is encouraged to aggressively pursue and correct the
misuse
of this definition. This includes issuing an alert to the public and
physicians,
as well as actively issuing letters to places misusing this definition.
The Committee
recommends that the CDC strongly
support the re-examination
and broadening of the Lyme disease surveillance case definition by the
Council of State and Territorial Epidemiologists. Voluntary and patient
groups should have input into this process. Currently there is just one
definition ('confirmed case') of seven possible categories. By
developing
other categories while leaving the current category intact, the true
number
of cases being diagnosed and treated will be more accurately counted,
lending
to improved public health planning for finding solutions to the
infection.
The CDC is
encouraged to include a broad range of scientific viewpoints
in the process of planning and executing their efforts. This means
including
community-based clinicians with extensive experience in treating these
patients, voluntary agencies who have advocacy in their mission, and
patient
advocates in planning committees, meetings, and outreach efforts.
|